Wellington Management Group’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Buy
286,212
+38,553
+16% +$127K ﹤0.01% 1773
2026
Q1
$666K Buy
+247,659
New +$688K ﹤0.01% 1742
2025
Q1
Sell
-180,157
Closed -$409K 1954
2024
Q4
$409K Buy
180,157
+23,106
+15% +$81.1K ﹤0.01% 1850
2024
Q3
$741K Sell
157,051
-1,758
-1% -$10.2K ﹤0.01% 1764
2024
Q2
$1.19M Sell
158,809
-849,450
-84% -$10.4M ﹤0.01% 1633
2024
Q1
$17.2M Buy
1,008,259
+468,383
+87% +$10.1M ﹤0.01% 984
2023
Q4
$12.3M Buy
539,876
+293,306
+119% +$4.93M ﹤0.01% 1059
2023
Q3
$3.75M Buy
+246,570
New +$3.37M ﹤0.01% 1351
2021
Q4
Sell
-534,700
Closed -$6.5M 2185
2021
Q3
$6.5M Hold
534,700
﹤0.01% 1424
2021
Q2
$4.6M Buy
534,700
+352,700
+194% +$3.47M ﹤0.01% 1524
2021
Q1
$2.02M Buy
182,000
+72,300
+66% +$883K ﹤0.01% 1624
2020
Q4
$1.37M Buy
+109,700
New +$1.42M ﹤0.01% 1564

Other funds holding CABA

Wellington Management Group's CABA Position: Q2 2026 in Review

Wellington Management Group increased its Cabaletta Bio (CABA) stake by 16% in Q2 2026, buying an estimated $127K and bringing the position to 286,212 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Wellington Management Group first reported a position in CABA in Q4 2020 and has held it in 12 quarters since. The position peaked at $17.2M in Q1 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Wellington Management Group held 286,212 shares of Cabaletta Bio worth $890K as of Q2 2026.
  • Wellington Management Group bought 38,553 Cabaletta Bio shares in Q2 2026, an estimated $127K.
  • Cabaletta Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1773 holding.
  • Wellington Management Group first reported a position in Cabaletta Bio in Q4 2020 and has held it in 12 quarters since.
  • Wellington Management Group's Cabaletta Bio position peaked at $17.2M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.